Timothy J. Fleck

1.2k total citations
17 papers, 962 citations indexed

About

Timothy J. Fleck is a scholar working on Neurology, Physiology and Dermatology. According to data from OpenAlex, Timothy J. Fleck has authored 17 papers receiving a total of 962 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Neurology, 6 papers in Physiology and 5 papers in Dermatology. Recurrent topics in Timothy J. Fleck's work include Dermatology and Skin Diseases (5 papers), Allergic Rhinitis and Sensitization (5 papers) and Amyotrophic Lateral Sclerosis Research (5 papers). Timothy J. Fleck is often cited by papers focused on Dermatology and Skin Diseases (5 papers), Allergic Rhinitis and Sensitization (5 papers) and Amyotrophic Lateral Sclerosis Research (5 papers). Timothy J. Fleck collaborates with scholars based in United States. Timothy J. Fleck's co-authors include Edward D. Hall, Paula K. Andrus, Mark E. Gurney, Mark E. Gurney, Jo A. Oostveen, Carol S. Himes, Steven L. Roberds, Brenda R. Ellerbrock, Andrea J. Gonzales and Robert B. McCall and has published in prestigious journals such as Neurology, Annals of Neurology and Brain Research.

In The Last Decade

Timothy J. Fleck

17 papers receiving 944 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timothy J. Fleck United States 12 534 290 228 212 168 17 962
Yu‐Mi Jeon South Korea 16 242 0.5× 276 1.0× 75 0.3× 135 0.6× 70 0.4× 28 693
Xiangyu Zheng China 16 263 0.5× 318 1.1× 17 0.1× 114 0.5× 219 1.3× 42 1.1k
Dengshun Wang United States 12 728 1.4× 269 0.9× 14 0.1× 544 2.6× 260 1.5× 21 1.2k
David Baranowski Canada 12 252 0.5× 171 0.6× 80 0.4× 170 0.8× 72 0.4× 15 649
M. Garrido Spain 12 196 0.4× 264 0.9× 7 0.0× 144 0.7× 62 0.4× 22 640
Axel Freischmidt Germany 16 692 1.3× 616 2.1× 357 1.6× 172 0.8× 254 1.5× 35 1.2k
Kayo Matsumoto Japan 16 330 0.6× 323 1.1× 21 0.1× 177 0.8× 81 0.5× 31 869
Xinling Yang China 14 273 0.5× 313 1.1× 10 0.0× 111 0.5× 201 1.2× 67 784
Lianshu Ding China 14 42 0.1× 457 1.6× 61 0.3× 92 0.4× 104 0.6× 38 825
Weisong Duan China 20 566 1.1× 513 1.8× 259 1.1× 175 0.8× 171 1.0× 49 1.1k

Countries citing papers authored by Timothy J. Fleck

Since Specialization
Citations

This map shows the geographic impact of Timothy J. Fleck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy J. Fleck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy J. Fleck more than expected).

Fields of papers citing papers by Timothy J. Fleck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy J. Fleck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy J. Fleck. The network helps show where Timothy J. Fleck may publish in the future.

Co-authorship network of co-authors of Timothy J. Fleck

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy J. Fleck. A scholar is included among the top collaborators of Timothy J. Fleck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy J. Fleck. Timothy J. Fleck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Fleck, Timothy J., et al.. (2022). Lack of Interference of Oclacitinib with the results of intradermal testing or allergen-specific IgE serology in Dermatophagoides farinae-sensitized beagle dogs. Veterinary Immunology and Immunopathology. 256. 110537–110537. 2 indexed citations
2.
Fleck, Timothy J., et al.. (2022). Speed of onset of a new chewable formulation of oclacitinib maleate (Apoquel®) in a canine model of IL‐31‐induced pruritus. Journal of Veterinary Pharmacology and Therapeutics. 45(4). 380–384. 3 indexed citations
3.
Fleck, Timothy J., et al.. (2021). Onset and duration of action of lokivetmab in a canine model of IL‐31 induced pruritus. Veterinary Dermatology. 32(6). 681–681. 12 indexed citations
4.
Gonzales, Andrea J., et al.. (2015). IL‐31‐induced pruritus in dogs: a novel experimental model to evaluate anti‐pruritic effects of canine therapeutics. Veterinary Dermatology. 27(1). 34–34. 47 indexed citations
5.
Gonzales, Andrea J., William R. Humphrey, Timothy J. Fleck, et al.. (2013). Interleukin‐31: its role in canine pruritus and naturally occurring canine atopic dermatitis. Veterinary Dermatology. 24(1). 48–48. 101 indexed citations
6.
Traas, Anne M., et al.. (2010). Ease of oral administration and owner-perceived acceptability of triglyceride oil, dissolving thin film strip, and gelatin capsule formulations to healthy cats. American Journal of Veterinary Research. 71(6). 610–614. 9 indexed citations
7.
Carter, Donald B., Adele M. Pauley, Denise D. McKinley, et al.. (2008). Changes in γ-secretase activity and specificity caused by the introduction of consensus aspartyl protease active motif in Presenilin 1. Molecular Neurodegeneration. 3(1). 6–6. 9 indexed citations
8.
Rank, Kenneth B., Adele M. Pauley, Keshab Bhattacharya, et al.. (2002). Direct interaction of soluble human recombinant tau protein with Aβ 1–42 results in tau aggregation and hyperphosphorylation by tau protein kinase II. FEBS Letters. 514(2-3). 263–268. 58 indexed citations
9.
Roberds, Steven L., et al.. (2001). Disease mechanisms revealed by transcription profiling in SOD1‐G93A transgenic mouse spinal cord. Annals of Neurology. 50(6). 730–740. 121 indexed citations
10.
Althaus, John S., Timothy J. Fleck, Dávid Becker, Edward D. Hall, & Philip F. VonVoigtlander. (1998). Azulenyl Nitrones: Colorimetric Detection of Oxyradical End Products and Neuroprotection in the Gerbil Transient Forebrain Ischemia/Reperfusion Model. Free Radical Biology and Medicine. 24(5). 738–744. 13 indexed citations
11.
Hall, Edward D., Paula K. Andrus, Jo A. Oostveen, Timothy J. Fleck, & Mark E. Gurney. (1998). Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS. Journal of Neuroscience Research. 53(1). 66–77. 149 indexed citations
12.
Andrus, Paula K., Timothy J. Fleck, Mark E. Gurney, & Edward D. Hall. (1998). Protein Oxidative Damage in a Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis. Journal of Neurochemistry. 71(5). 2041–2048. 228 indexed citations
13.
Hall, Edward D., Timothy J. Fleck, & Jo A. Oostveen. (1998). Comparative neuroprotective properties of the benzodiazepine receptor full agonist diazepam and the partial agonist PNU-101017 in the gerbil forebrain ischemia model. Brain Research. 798(1-2). 325–329. 13 indexed citations
14.
Gurney, Mark E., Timothy J. Fleck, Carol S. Himes, & Edward D. Hall. (1998). Riluzole preserves motor function in a transgenic model of familial amyotrophic lateral sclerosis. Neurology. 50(1). 62–66. 137 indexed citations
15.
Hall, Edward D., Paula K. Andrus, Jo A. Oostveen, Timothy J. Fleck, & Mark E. Gurney. (1998). Relationship of oxygen radical‐induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS. Journal of Neuroscience Research. 53(1). 66–77. 8 indexed citations
16.
Andrus, Paula K., Timothy J. Fleck, Jo A. Oostveen, & Edward D. Hall. (1997). Neuroprotective effects of the novel brain-penetrating pyrrolopyrimidine antioxidants U-101033E and U-104067F against post-ischemic degeneration of nigrostriatal neurons. Journal of Neuroscience Research. 47(6). 650–654. 33 indexed citations
17.
Hall, Edward D., Paula K. Andrus, Timothy J. Fleck, et al.. (1997). Neuroprotective Properties of the Benzodiazepine Receptor, Partial Agonist PNU-101017 in the Gerbil Forebrain Ischemia Model. Journal of Cerebral Blood Flow & Metabolism. 17(8). 875–883. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yu‐Mi Jeon Breakdown of academic impact, for papers by Xiangyu Zheng Breakdown of academic impact, for papers by Dengshun Wang Breakdown of academic impact, for papers by David Baranowski Breakdown of academic impact, for papers by M. Garrido Breakdown of academic impact, for papers by Axel Freischmidt Breakdown of academic impact, for papers by Kayo Matsumoto Breakdown of academic impact, for papers by Xinling Yang Breakdown of academic impact, for papers by Lianshu Ding Breakdown of academic impact, for papers by Weisong Duan
Rankless by CCL
2026